Drug Repackager Enjoined Because Of FDA Concerns About Mislabeling

COLUMBUS, Ohio - A drug repackager and its principals on Sept. 17 consented to a permanent injunction after the Food and Drug Administration said they were mislabeling drugs (United States of America v. Shamrock Medical Solutions Group, LLC, et al., No. 2:13-590, S.D. Ohio, Eastern Div.).

Access this news story on lexis.com®